News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL
NCCN/prnewswire.com
Dec 3, 2024, 09:45

Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL

National Comprehensive Cancer Network shared a post on LinkedIn:

“Join us for live symposia this week! Explore expert insights on Bladder Cancer on Wednesday, December 4, and the latest updates on CLL on Friday, December 6.

Learn more.”

More posts featuring NCCN.

bladder cancer cancer chronic lymphocytic leukemia CLL National Comprehensive Cancer Network NCCN OncoDaily Oncology
Special Coverage
Blog
Dec 3, 2024, 11:55
Save your date for the 2025 NFCR Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship - AFCR
Blog
Dec 3, 2024, 11:53
OncoInfluencers to Follow on Social Media: Dr. Ivy Riano
Blog
Dec 3, 2024, 11:50
Jason Westin: Excited to be Nominated for ASCO Board of Directors
Blog
Dec 3, 2024, 11:48
Petros Grivas: Kind reminder for active members to participate in ASCO election
Blog
Dec 3, 2024, 11:46
Tedros Adhanom Ghebreyesus: Vietnam makes Bold decision to Protect Citizens from Vaping and Tobacco
Blog
Dec 3, 2024, 11:43
Empowering cancer researchers from LMIC - IARC
Blog
Dec 3, 2024, 10:33
Sam Merriel: Join Manchester’s Primary Care Cancer Team with a PhD Studentship on Prostate Cancer Inequalities
Blog
Dec 3, 2024, 09:45
Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL
Blog
Dec 3, 2024, 09:35
Dégi László Csaba: A Summit To Remember
Blog
Dec 3, 2024, 09:23
Chemoradiotherapy for gastric cancer shows no survival benefit - EORTC
Blog
Dec 3, 2024, 09:20
Janine Austin Clayton: Announcing new awards for Health Equity Research
Insight
Dec 3, 2024, 09:17
UPEP 24 hour urine protein study is not necessary for response assessment in Myeloma